OR4K2 (Olfactory Receptor Family 4 Subfamily K Member 2) is a G-protein coupled receptor involved in olfactory sensing. It belongs to the large family of olfactory receptors that interact with odorant molecules in the nose to initiate neuronal responses that trigger smell perception. OR4K2 is a multi-pass membrane protein with a molecular weight of approximately 35kDa .
Research on OR4K2 is valuable for understanding:
The mechanisms of olfactory signal transduction
Structure and function of G-protein coupled receptors
The genetics and evolution of the olfactory receptor gene family, which is the largest in the genome
Potential roles in non-olfactory tissues, as ectopic expression has been documented
Selection should be based on several critical factors:
Application compatibility: Different antibodies perform optimally in different applications:
For Western blot: Look for antibodies validated specifically for WB with recommended dilutions of 1:500-1:2000
For immunofluorescence: Choose antibodies validated for IF with dilutions typically around 1:200-1:1000
For ELISA applications: Select antibodies tested for ELISA with appropriate dilutions (often much higher, e.g., 1:40000)
Species cross-reactivity: Ensure the antibody recognizes OR4K2 in your experimental organism:
Epitope considerations: Most OR4K2 antibodies target the C-terminal region. This is important when:
Creating fusion proteins (avoid C-terminal tags if using these antibodies)
Studying truncated variants
Investigating post-translational modifications
Validation data: Prioritize antibodies with substantial validation:
Based on published methodologies:
Sample preparation:
Protein denaturation and loading:
Heat samples at 95°C for 5 minutes in Laemmli buffer
Load 20-40μg total protein per lane
Gel electrophoresis and transfer:
10-12% SDS-PAGE gels are suitable for resolving the 35kDa OR4K2 protein
Transfer to PVDF membranes at 100V for 1 hour or 30V overnight
Blocking and antibody incubation:
Detection controls:
The expected result is a band at approximately 35kDa, which corresponds to the full-length OR4K2 protein.
Potential solutions:
Increase antibody concentration (use 1:500 instead of 1:2000)
Extend primary antibody incubation time to overnight at 4°C
Verify protein expression levels in your experimental system (OR4K2 may have tissue-specific expression)
Use fresh antibody aliquots and avoid repeated freeze-thaw cycles
Consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity
Optimize protein extraction protocol for membrane proteins using appropriate detergents
Potential solutions:
Increase blocking time or concentration (try 5% BSA instead of milk)
Extend wash steps (5 x 5 minutes with TBST)
Decrease primary antibody concentration (try 1:2000 instead of 1:500)
Use fresh blocking solutions
Pre-absorb antibody with non-specific proteins
Consider using monoclonal antibodies for higher specificity
Potential solutions:
Standardize fixation protocols (4% paraformaldehyde for 15 minutes is commonly effective)
Optimize permeabilization conditions for membrane proteins
Use positive control samples with known OR4K2 expression
Consider antigen retrieval methods if working with fixed tissues
Based on manufacturer recommendations :
Storage conditions:
Shipping and handling:
Working solution preparation:
Dilute in fresh buffer solutions immediately before use
For ELISA applications, prepare dilutions in appropriate assay buffers
When working with diluted antibody solutions, maintain cold temperatures and use within 24 hours
Single-cell and subcellular localization studies require specialized approaches:
Immunofluorescence optimization for subcellular localization:
Use confocal microscopy for precise localization
Co-stain with organelle markers (e.g., membrane markers like Na+/K+ ATPase)
Dilute OR4K2 antibodies at 1:200-1:1000 for optimal signal-to-noise ratio
Consider super-resolution microscopy techniques for detailed membrane localization
The Human Protein Atlas provides subcellular localization data that can serve as reference
Single-cell analysis techniques:
Flow cytometry can be used with permeabilized cells and appropriate fluorophore-conjugated secondary antibodies
For single-cell transcriptomics correlation, combine with RNA-FISH techniques
Mass cytometry (CyTOF) may be employed for multiple parameter analysis at single-cell resolution
Single-cell proteomic approaches can validate antibody binding at individual cell level
Considerations for olfactory receptor trafficking:
OR4K2, like other olfactory receptors, undergoes complex trafficking
Use pulse-chase experiments with OR4K2 antibodies to track protein movement
Live-cell imaging may require creation of tagged OR4K2 constructs for validation
Comprehensive validation approaches include:
Genetic validation methods:
Use CRISPR/Cas9 knockout cell lines lacking OR4K2 as negative controls
siRNA knockdown experiments to demonstrate specificity
Overexpression systems with tagged OR4K2 for co-localization studies
Biochemical validation:
Cross-reactivity assessment:
Test antibodies on tissues/cells from different species if cross-reactivity is claimed
Evaluate potential cross-reactivity with closely related olfactory receptors
Perform sequence alignment analysis of the immunogen peptide against related proteins
Technical validation:
Compare results from multiple antibodies targeting different epitopes
Use different detection methods (e.g., WB, IF, ELISA) to confirm consistency
Validate with orthogonal methods like RNA expression data
Several methodological approaches can be employed:
Analysis of receptor expression in disease models:
Quantitative Western blot analysis using calibrated OR4K2 antibodies
Immunohistochemistry of olfactory epithelium in normal vs. diseased tissue
Flow cytometry for quantifying receptor-positive cells in disaggregated tissues
Functional correlation studies:
Combine antibody labeling with calcium imaging or electrophysiology
Correlate receptor expression levels with olfactory sensory neuron activity
Use in animal models of olfactory dysfunction (e.g., aging, neurodegenerative diseases)
Potential limitations and controls:
Species differences in OR4K2 sequence may limit use in some animal models
Include age-matched controls when studying developmental or aging effects
Consider the natural variability in olfactory receptor expression
Modern multiplexed approaches include:
Antibody array systems:
OR4K2 antibodies can be spotted onto antibody microarrays
Include appropriate controls and standardization curves
Validate signal specificity in multiplexed format separately
Multiplexed immunofluorescence techniques:
Sequential immunostaining with OR4K2 antibodies and other markers
Spectral unmixing for multiple fluorophores
Cyclic immunofluorescence for highly multiplexed imaging
Mass cytometry and imaging mass cytometry:
Metal-conjugated OR4K2 antibodies can be used in CyTOF systems
Enables simultaneous detection of dozens of proteins
Requires careful titration and validation in the multiplexed context
ELISA-based multiplexing:
Guidelines for rigorous data interpretation:
Western blot quantification approaches:
Use total protein normalization rather than single housekeeping genes
Employ linear range detection methods
Include calibration curves with recombinant standards when possible
Present data as fold-change relative to appropriate controls
ELISA data analysis:
Statistical considerations:
Perform appropriate statistical tests based on data distribution
Consider biological vs. technical replicates in experimental design
Use power analysis to determine adequate sample sizes
Account for batch effects in multi-experiment analyses
Integrative approaches include:
Multi-omics integration methods:
Correlate protein expression data from antibody-based detection with transcriptomic data
Integrate with genomic data on OR4K2 genetic variants
Combine with metabolomic data for functional pathway analysis
Use machine learning approaches for pattern recognition across multiple data types
Pathway and network analysis:
Place OR4K2 protein data in context of G-protein coupled receptor signaling networks
Consider interaction partners identified through co-immunoprecipitation
Map to known olfactory transduction pathways
Use pathway enrichment analysis for functional interpretation
Visualization techniques:
Create multi-dimensional visualizations incorporating OR4K2 antibody data
Use heat maps for comparing expression across different conditions
Develop interactive visualizations for exploring relationships between variables
Consider temporal aspects when integrating time-course data
Emerging antibody technologies with potential applications include:
Single-domain antibodies and nanobodies:
Smaller size allows better penetration into tissues and access to cryptic epitopes
Potential for detecting conformational states of OR4K2 as a GPCR
May provide new tools for studying OR4K2 in live-cell applications
Recombinant antibody technologies:
Engineered antibody fragments:
Fab and scFv fragments for improved tissue penetration
Bispecific antibodies for co-detection of OR4K2 with signaling partners
Intrabodies for tracking OR4K2 in living cells
Novel research directions include:
Ectopic expression studies:
Investigation of OR4K2 expression in non-olfactory tissues
Potential roles in sperm chemotaxis or other chemosensory functions
Connections to other GPCR signaling networks in diverse cell types
Drug discovery applications:
Antibody-based screening for compounds that modulate OR4K2 activity
Conformational antibodies that distinguish active vs. inactive receptor states
Target validation for olfactory-based therapeutics
Methodological innovations:
Proximity labeling approaches using OR4K2 antibodies
CRISPR-based tagging for endogenous tracking
Optogenetic or chemogenetic tools combined with antibody validation